Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department

November 18, 2025 updated by: Michael Gottlieb, Rush University Medical Center

Combating Health Disparities Using Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department

The goal of this clinical trial is to learn if using point-of-care ultrasound (POCUS) can increase participant engagement and changes in behavior among adults with risk factors for pre-symptomatic heart failure presenting to the emergency department. The main questions it aims to answer are:

  1. Does POCUS increase understanding of heart failure and the likelihood to improve diet, exercise, and follow up?
  2. Does POCUS improve diet, exercise, follow up, and self-efficacy at three months post-intervention?

Researchers will compare an educational intervention with versus without POCUS to see if POCUS works to improve outcomes.

Participants will:

Receive either the educational intervention alone or an educational intervention plus POCUS. They will report the difference in their understanding and likelihood to improve diet, exercise, and follow up immediately post-intervention. They will also report changes in diet, exercise, follow up, and self-efficacy at three months post-intervention.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Must be 45 years of age or older
  • Must have high blood pressure, diabetes mellitus, or obesity (body mass index ≥30 kg/m2)

Exclusion Criteria:

  • Symptoms of acute heart failure (difficulty breathing, leg swelling)
  • History of heart failure
  • Unable to tolerate an ultrasound examination
  • No access to a phone for follow up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Educational Intervention Alone
This will include only the educational intervention (without ultrasound)
Experimental: Ultrasound and Educational Intervention
This will include the educational intervention combined with a point-of-care ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Primary Care Follow Up
Time Frame: 3 Months Post-Intervention
Defined as the presence or absence of a follow up visit with a primary care provider at 3 months
3 Months Post-Intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Likelihood to Follow Up with a Primary Care Physician within the 3 Months Post-Intervention
Time Frame: Baseline and Immediately Post-Intervention
Ordinal scale of 1 (very unlikely) to 7 (very likely)
Baseline and Immediately Post-Intervention
Self-perceived knowledge of heart failure
Time Frame: Baseline and Immediately Post-Intervention
Ordinal scale of 1 (no knowledge) to 7 (extremely knowledgeable)
Baseline and Immediately Post-Intervention
Degree of motivation and self-efficacy using a modified High Blood Pressure Self-Care Profile (HBP-SCP) Motivation and Self-Efficacy tool
Time Frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Likelihood to change their fruit and vegetable intake using the Stages of Change tools for Fruits and Vegetables
Time Frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Likelihood to change their fat intake using the Stages of Change for Dietary Fat tool
Time Frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Likelihood to change their exercise using the Stages of Change for Physical Activity
Time Frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Change in diet quality using the Mediterranean Eating Pattern for Americans tool
Time Frame: Baseline and 3 Months Post-Intervention
Baseline and 3 Months Post-Intervention
Change in exercise status using the Exercise Vital Sign tool
Time Frame: Baseline and 3 Months Post-Intervention
Baseline and 3 Months Post-Intervention
Satisfaction with the educational intervention
Time Frame: Immediately Post-Intervention and 3 Months Post-Intervention
Ordinal scale of 1 (very unsatisfied) to 7 (very satisfied)
Immediately Post-Intervention and 3 Months Post-Intervention
New medications or changes in their anti-hypertensive medication use
Time Frame: 3 Months Post-Intervention
3 Months Post-Intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Gottlieb, MD, Rush University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 13, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

January 6, 2025

First Submitted That Met QC Criteria

January 6, 2025

First Posted (Actual)

January 10, 2025

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 23112905
  • P50MD017349 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Diseases

Clinical Trials on Educational Intervention Alone

Subscribe